Actively Recruiting

Age: 40Years - 75Years
All Genders
NCT05563623

The Beijing Angle Closure Progression Study

Led by Peking University People's Hospital · Updated on 2022-10-03

825

Participants Needed

1

Research Sites

438 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The Beijing angle closure progression study (BAPS) aims to explore the 5-year incidence of PACS progressing to PAC or PACG and to determine the possible risk factors of disease progression, which may provide the evidence for choosing the accurate strategies in the management of PACS.

CONDITIONS

Official Title

The Beijing Angle Closure Progression Study

Who Can Participate

Age: 40Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • "Static" gonioscopy identifying 6 or more clock hours of angle circumference in which the posterior (usually pigmented) trabecular meshwork cannot be seen in both eyes with no peripheral anterior synechiae, and normal intraocular pressure (IOP), optic nerve and visual field.
  • Able to provide informed consent
Not Eligible

You will not qualify if you...

  • Any evidence of primary angle closure (a narrow angle as defined above, but with PAS and/or IOP > 21 mmHg) or primary angle closure glaucoma (visual field defect or glaucomatous optic neuropathy).
  • Previous intraocular surgery or laser treatment, such as cataract surgery, laser trabeculoplasty, trabeculectomy, laser peripheral iridectomy, and laser iridoplasty
  • Sign of prior acute attack, such as glaucomatous fleck, keratic precipitates, or iris atrophy.
  • Anterior segment structural abnormalities shown by examination, such as iris or ciliary body tumor.
  • Severe health problems precluding follow-up such as end-stage heart disease, kidney disease, or lung disease, or terminal cancer.
  • Severe eye diseases, such as cataract, macular disease, and retinal detachment.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University People's Hospital

Beijing, Beeijing, China, 100044

Actively Recruiting

Loading map...

Research Team

H

Huijuan Wu, M.D. Ph.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Beijing Angle Closure Progression Study | DecenTrialz